Our research on pancreatic cancer

Although survival rates for several types of cancer have improved over the years, pancreatic cancer is particularly hard to treat, partly because it’s often diagnosed late. That’s why research into pancreatic cancer is one of our key priorities.

Help us beat cancer sooner

We receive no government funding for our research. Our life-saving work relies on the money you give us.

Find out how you can support us

 

Pancreatic cancer and my family

Richie's mother sadly passed away after being diagnosed with pancreatic cancer. In 2009 Richie had the same diagnosis, but after surgery and chemotherapy he is now in remission. 

Promising research into pancreatic cancer

Jen Morton’s research has pinpointed a genetic fault in a sub-type of pancreatic cancer and matched it up with a drug, named rapamycin. Early results indicate the drug can actually shrink the tumour.

Extending life

Prof Jeff Evans will lead a trial in the UK to find out if Abraxane can improve life expectancy after surgical removal of pancreatic cancer.

 

Our strategy to beat cancer sooner

Our vision is to bring forward the day when all cancers are cured.Our new strategy will give us the foundations we need to tackle the challenges ahead.

More about pancreatic cancer

Find out about symptoms, risk factors and causes of pancreatic cancer and treatment on our Cancer Help pages.

Read the latest statistics for pancreatic cancer.

Share this page